No definition available.
Other infections specific to the perinatal period
P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
209 |
4. Check minimum number of eventsNone |
209 |
5. Include endpointsNone |
209 |
6. Filter based on genotype QC (FinnGen only) |
209 |
Control definitions (FinnGen only)
- Control exclude
- P16_INFECTIONS_SPECIFIC_PERINA_PERIOD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P3
- Name in latin
- Alii infectiones temporis perinatalis specificae
Similar endpoints
↥List of similar endpoints to
Other infections specific to the perinatal period
based on the number of shared cases.
Similar with more cases:
- Infections specific to the perinatal period
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 15148 | 6214 | 8934 |
| Only index persons | 9358 | 3723 | 5635 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.22 | 0.18 | 0.25 |
| Only index persons | 0.18 | 0.14 | 0.22 |
| Median age at first event (years) | |||
| Whole population | - | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 209 | 109 | 100 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 185
- Matched controls
- 1860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P39.9
ICD-10 Finland
Infection specific to the perinatal period, unspecified
+∞
176.3
140
*
P39.1
ICD-10 Finland
Neonatal conjunctivitis and dacryocystitis
+∞
23.4
22
*
P36.90
ICD-10 Finland
Suspected bacterial sepsis of newborn
+∞
11.6
11
*
P39.4
ICD-10 Finland
Neonatal skin infection
+∞
11.6
11
*
P01.10
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery
14.5
9.9
16
12
P39.0
ICD-10 Finland
Neonatal infective mastitis
+∞
9.5
9
*
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
7.1
7.3
17
26
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40761536) Microorganisms panel - Urine sediment
24
105
2.45
3.68
3.1
3.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
7
8.77
3.28
2.2
1.6
pg
32.3
32.9
—
6
7
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
0
84
0.00
3.19
0.0
2.1
—
31.0
—
0
63
(3025159) Blasts/100 leukocytes in Blood
20
89
2.38
2.97
6.5
6.2
%
0.0
0.0
—
5
23
(3021440) Promyelocytes/100 leukocytes in Blood
20
92
2.30
2.77
6.4
6.1
%
0.0
0.0
—
5
28
(3019225) pH of Specimen
0
69
0.00
2.65
0.0
5.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
20
96
2.20
2.52
6.4
6.0
%
0.2
0.6
—
5
31
(3000492) Spirometry study
22
116
2.00
2.20
1.4
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
45
300
1.64
2.11
3.5
3.4
estimate
0.0
0.0
0.00
22
108
(3023368) Bacteria identified in Blood by Culture
36
226
1.71
2.11
3.6
4.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
55
0.00
2.10
0.0
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
36
525
0.62
1.85
4.0
4.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
17
3.60
1.85
1.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
43
293
1.59
1.84
3.5
3.4
ph
7.4
7.4
—
8
55
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
12
4.24
1.83
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
13
3.91
1.72
1.0
1.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
17
90
1.97
1.70
2.5
2.7
pmol/l
4.9
5.1
0.71
17
81
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
20
3.05
1.59
6.2
6.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
33
2.48
1.55
18.8
14.8
%
71.1
71.9
—
8
33
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
44
0.00
1.53
0.0
5.8
—
93.0
—
0
44
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
44
0.00
1.53
0.0
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
106
894
1.37
1.47
9.5
11.4
e9/l
0.0
0.0
0.00
82
677
(3044640) Blood type and Crossmatch panel - Blood
24
365
0.61
1.45
2.3
3.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
56
425
1.43
1.44
3.3
3.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
155
1396
1.42
1.42
10.1
11.7
mmol/l
3.9
3.9
0.15
150
1341
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
244
0.54
1.41
1.0
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
174
1609
1.48
1.30
9.6
10.4
mg/l
21.3
22.4
0.16
116
1046
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
62
765
0.73
1.27
1.6
1.8
u/ml
0.3
2.3
3.70
11
142
(3041096) Erythrocytes [Presence] in Urine by Automated
43
318
1.44
1.27
3.5
2.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
13
70
1.91
1.26
1.5
1.3
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
6
25
2.44
1.25
1.7
4.8
kpa
8.5
9.1
—
6
25
(3013290) Carbon dioxide [Partial pressure] in Blood
6
25
2.44
1.25
1.7
4.8
kpa
5.6
4.9
—
6
25
(3007853) Bacteria identified in Skin by Aerobe culture
13
222
0.56
1.23
1.6
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
154
1400
1.38
1.22
10.1
11.7
mmol/l
139.5
139.5
0.01
149
1354
(3009214) Lutropin [Units/volume] in Serum or Plasma
22
143
1.60
1.17
2.2
2.3
u/l
7.0
5.7
0.45
16
100
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
20
2.53
1.15
1.2
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
40
2.04
1.13
18.8
13.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
41
1.99
1.10
4.1
3.9
e9/l
2.6
3.1
—
8
41
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
41
1.99
1.10
4.4
4.4
%
43.0
50.3
—
8
41
(3026782) Osmolality of Urine
39
293
1.41
1.06
3.1
3.4
mosm/kgh2o
468.1
629.5
3.47
32
263
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
5
108
0.45
1.04
7.8
8.7
%
173.2
167.3
—
5
108
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
9
47
1.95
1.03
2.7
6.5
mg/l
202.8
454.3
—
9
47
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
21
304
0.66
1.03
2.2
3.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
124
1365
0.77
1.02
4.5
3.7
mu/l
2.1
2.0
0.41
111
1282
(3026389) Candida sp identified in Specimen by Organism specific culture
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
13
78
1.71
0.93
1.5
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
7
130
0.52
0.91
6.7
8.8
%
96.1
94.3
—
7
130
(3003694) ABO and Rh group [Type] in Blood
39
493
0.74
0.90
1.8
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
18
120
1.55
0.88
1.8
1.4
pmol/l
508.5
63809944.8
0.50
11
105
(36660697) Celiac disease serology panel - Serum
22
304
0.69
0.86
1.3
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
164
1538
1.30
0.82
12.6
14.6
%
13.2
13.0
1.29
157
1505
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
33
1.84
0.79
1.2
2.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
25
0.00
0.79
0.0
6.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
27
0.00
0.78
0.0
1.9
—
40.0
—
0
27
(3000093) Morphology [Interpretation] in Blood Narrative
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
51
422
1.27
0.74
4.2
4.5
e6/l
0.1
0.2
1.05
34
323
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
57
481
1.25
0.71
4.8
4.8
—
—
—
0
0
(4010399)
13
85
1.56
0.70
1.5
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
51
426
1.26
0.69
4.4
4.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
169
1763
0.78
0.67
4.0
3.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
43
1.65
0.67
3.1
6.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
54
458
1.24
0.64
4.9
4.6
e6/l
17.5
27.4
0.45
38
361
(40760892) CBC W Ordered Manual Differential panel - Blood
43
357
1.26
0.61
5.8
4.9
—
—
—
0
0
(3013512) EKG study
25
193
1.33
0.61
2.2
2.4
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.3
—
29.5
—
0
6
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.3
—
21.4
—
0
5
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
20
0.00
0.60
0.0
1.3
—
115.5
—
0
20
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
22
0.00
0.59
0.0
1.7
—
6.8
—
0
10
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
3.3
—
6.1
—
0
14
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
68
766
0.83
0.58
2.3
4.5
u/l
22.8
25.2
0.39
59
740
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
23
177
1.34
0.57
1.2
1.2
iu/ml
8.8
14.0
—
5
37
(3035350) Ketones [Presence] in Urine by Test strip
70
620
1.19
0.54
3.6
3.3
estimate
0.0
0.0
0.00
20
106
(3021601) Nitrite [Presence] in Urine by Test strip
70
621
1.19
0.53
5.1
4.7
estimate
0.0
0.0
0.00
22
114
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
83
913
0.85
0.53
2.9
2.8
mmol/l
4.3
4.3
0.23
78
867
(3000850) Epithelial cells [#/volume] in Urine
37
308
1.24
0.52
4.5
3.4
e6/l
8.2
8.3
0.01
30
275
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
40
1.51
0.52
1.7
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
75
1.49
0.51
1.0
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
81
891
0.85
0.51
2.7
2.7
mmol/l
1.4
1.4
0.40
75
840
(3026361) Erythrocytes [#/volume] in Blood
190
1845
1.32
0.49
13.5
15.0
e12/l
4.6
4.7
0.11
174
1755
(3009261) Glucose [Presence] in Urine by Test strip
70
626
1.18
0.48
3.7
3.3
estimate
0.0
0.0
0.00
22
109
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
35
293
1.23
0.48
5.2
8.2
mmol/l
1.1
1.2
0.14
22
208
(3042936) Bacteria identified in Isolate by Culture
11
153
0.70
0.48
2.1
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
117
0.67
0.47
1.3
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
8
116
0.68
0.47
1.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
48
1.47
0.47
1.1
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
48
1.47
0.47
1.1
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
190
1847
1.30
0.47
13.5
15.0
e9/l
6.8
6.6
0.75
175
1756
(3000764) Benzodiazepines [Presence] in Urine
22
272
0.79
0.45
1.3
1.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
156
1490
1.18
0.45
7.4
8.6
u/l
23.4
24.7
0.48
146
1425
(3027944) Amphetamines [Presence] in Urine
22
271
0.79
0.44
1.3
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
22
271
0.79
0.44
1.3
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
22
271
0.79
0.44
1.3
1.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
189
1839
1.28
0.43
13.6
15.1
e9/l
269.2
268.1
0.08
173
1754
(3050129) First trimester maternal screen panel - Serum or Plasma
6
92
0.64
0.43
1.5
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
31
1.63
0.43
2.8
5.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
94
0.63
0.43
2.3
2.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
6
94
0.63
0.43
2.3
2.2
—
89.3
—
0
6
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
57
1.42
0.42
3.0
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
8
58
1.39
0.42
5.8
11.8
mmol/l
22.3
23.3
—
8
52
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
36
307
1.21
0.42
1.6
1.4
pmol/l
101.6
100.0
0.07
19
161
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
33
1.53
0.41
1.2
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
78
849
0.87
0.41
2.7
2.6
mmol/l
1.3
1.1
1.08
73
809
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
34
1.48
0.40
1.0
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
62
685
0.86
0.40
1.5
1.7
g/l
1.7
1.6
0.13
33
359
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
18
0.00
0.40
0.0
1.2
—
86.4
—
0
18
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
115
1217
0.88
0.40
4.3
3.3
pmol/l
14.4
14.3
0.10
102
1086
(3042733) HLA Ab [Presence] in Serum
0
19
0.00
0.39
0.0
2.6
—
—
—
0
0
(4306422)
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
27
320
0.82
0.39
1.4
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
9
67
1.36
0.38
2.6
2.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
212
0.78
0.38
1.3
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
22
180
1.25
0.37
1.8
2.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
189
0.78
0.36
1.5
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
21
252
0.81
0.34
1.3
1.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
61
554
1.14
0.34
5.7
5.2
e6/l
67.7
62.4
0.04
39
372
(3017732) Neutrophils [#/volume] in Blood
6
89
0.66
0.33
3.8
1.3
e9/l
3.1
3.9
—
6
83
(3022313) Gas panel - Capillary blood
30
258
1.19
0.33
4.9
8.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
47
1.28
0.32
1.7
2.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
99
930
1.12
0.32
7.8
6.3
ml/min/173m2
114.2
115.0
0.12
64
583
(3001122) Ferritin [Mass/volume] in Serum or Plasma
74
796
0.89
0.31
4.5
3.5
ug/l
75.6
51.4
0.36
69
747
(3044889) 12 lead EKG panel
69
636
1.13
0.31
2.2
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
48
530
0.88
0.31
3.1
2.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
108
1023
1.11
0.30
4.7
4.6
mm/h
8.7
6.7
0.68
102
948
(3003327) Ova and parasites identified in Stool by Light microscopy
8
108
0.73
0.29
1.6
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
56
1.26
0.29
1.1
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
89
944
0.90
0.29
2.1
2.2
mmol/l
5.6
5.3
0.43
75
848
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
507
0.88
0.29
3.0
2.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
172
1674
1.15
0.29
11.5
13.1
%
39.7
39.9
0.13
143
1480
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
30
262
1.17
0.28
3.6
4.3
e6/l
3.6
3.2
0.07
15
156
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
17
140
1.23
0.28
1.9
2.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
74
791
0.90
0.28
3.5
2.9
mmol/mol
36.8
36.6
0.05
69
744
(42870588) Differential panel, method unspecified - Blood
76
712
1.10
0.25
7.7
10.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
265
1.15
0.25
1.4
1.7
—
—
—
0
0
(3015736) pH of Urine
55
507
1.11
0.24
3.4
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
29
256
1.15
0.24
3.6
4.2
e6/l
0.5
0.8
0.24
13
149
(3000991) Gas panel - Venous blood
33
295
1.14
0.24
7.5
12.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
37
1.36
0.23
1.0
5.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
37
1.36
0.23
1.2
2.3
—
—
—
0
0
(4062490)
5
38
1.32
0.23
1.4
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
32
286
1.14
0.23
2.7
1.7
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
92
0.75
0.23
2.1
2.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
85
894
0.92
0.22
2.5
2.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
71
667
1.10
0.22
9.6
11.3
mmol/l
1.2
1.2
0.05
62
605
(3002256) Pathology report gross observation
8
104
0.76
0.21
1.1
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
4.4
—
254.9
—
0
10
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.4
—
34.7
—
0
10
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
5.5
—
0.6
—
0
10
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.4
—
27.0
—
0
10
(40757494) Bilirubin.total [Moles/volume] in Blood
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
28.9
—
0
10
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
17
145
1.19
0.21
1.8
2.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
156
1596
0.91
0.21
11.6
13.9
g/l
335.3
335.3
0.00
156
1573
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
13
0.00
0.21
0.0
1.0
—
84.0
—
0
6
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
13
0.00
0.21
0.0
1.4
—
63.2
—
0
6
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.6
—
18.7
—
0
13
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
80
1.26
0.20
4.8
3.4
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
49
1.23
0.20
1.7
2.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
38
348
1.11
0.19
2.8
2.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
128
1.18
0.18
1.7
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
59
1.19
0.18
1.4
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
93
892
1.07
0.17
4.5
4.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
120
0.82
0.17
1.0
1.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
66
0.75
0.17
1.8
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
86
895
0.93
0.16
2.7
2.7
mmol/l
2.6
2.6
0.19
80
839
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
76
0.78
0.16
1.0
1.1
—
8.8
—
0
13
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
75
0.79
0.16
1.0
1.2
—
—
—
0
0
(4035726)
6
77
0.77
0.16
1.0
1.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
35
323
1.10
0.15
12.4
13.0
mmol/l
25.0
25.1
0.04
35
323
(3048689) Calprotectin [Mass/mass] in Stool
34
367
0.91
0.15
2.9
3.7
ug/g
128.7
91.2
0.43
26
282
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
82
1.10
0.15
1.2
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
19
169
1.14
0.15
1.2
1.1
u/ml
1.0
9.6
—
5
56
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
51
481
1.08
0.14
4.8
8.0
umol/l
12.5
12.5
0.00
45
444
(40761511) CBC panel - Blood by Automated count
163
1600
1.08
0.14
7.3
7.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
128
0.85
0.14
1.2
2.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
25
228
1.11
0.14
1.3
1.4
—
13.1
—
0
8
(3021879) Hepatitis B virus core Ab [Presence] in Serum
17
151
1.14
0.13
1.4
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
96
990
0.94
0.13
8.5
10.4
e9/l
0.2
0.2
0.16
82
852
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
34
363
0.92
0.12
2.0
1.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
94
968
0.95
0.12
8.2
9.7
e9/l
0.0
0.0
2.06
79
817
(3001604) Monocytes [#/volume] in Blood
94
968
0.95
0.12
8.1
9.7
e9/l
0.6
0.5
0.54
79
816
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
48
504
0.94
0.11
1.6
1.8
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
5
47
1.06
0.09
1.4
4.6
%
28.2
28.2
—
5
47
(3002032) Base excess in Venous blood by calculation
34
321
1.07
0.09
9.9
11.3
mmol/l
0.7
1.4
0.57
28
258
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
53
1.13
0.09
1.3
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
56
1.07
0.08
1.3
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
6
58
1.03
0.08
11.7
14.5
%
97.4
95.1
—
6
58
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
61
0.81
0.08
1.2
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
117
1.12
0.08
1.9
2.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
10
88
1.14
0.08
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
133
0.90
0.08
1.8
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
143
0.90
0.08
1.7
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
75
1.07
0.07
1.3
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
33
346
0.94
0.07
2.9
2.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
82
0.85
0.07
1.1
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
33
314
1.06
0.07
2.4
1.8
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
34
324
1.06
0.07
10.0
11.2
kpa
6.0
5.9
0.07
34
310
(3037121) Protein [Mass/volume] in Urine
8
92
0.86
0.07
3.1
10.7
g/l
0.1
0.3
—
8
77
(40758558) Short blood count panel - Blood
52
536
0.96
0.06
6.0
10.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
88
863
1.03
0.05
6.2
5.4
u/l
116.3
117.5
0.05
82
806
(3019198) Lymphocytes [#/volume] in Blood
98
995
0.97
0.05
7.9
9.6
e9/l
2.2
2.1
0.26
84
861
(3011397) Hemoglobin [Presence] in Urine by Test strip
35
337
1.05
0.05
2.9
3.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
31
299
1.04
0.04
2.5
2.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
15
141
1.07
0.03
1.4
1.2
u/ml
4.0
3.0
—
9
38
(3013650) Neutrophils [#/volume] in Blood by Automated count
104
1027
1.02
0.03
9.1
11.3
e9/l
3.5
3.4
0.20
87
868
(3019150) Specific gravity of Urine by Refractometry
32
329
0.97
0.02
3.2
2.9
kg/l
1.0
1.0
—
6
37
(3017143) Hepatitis C virus Ab [Presence] in Serum
27
261
1.04
0.02
1.9
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
42
411
1.03
0.02
2.7
3.8
mg/l
2.6
2.7
0.10
37
361
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
93
1.08
0.02
1.6
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
32
312
1.03
0.01
10.1
10.9
kpa
5.3
5.0
0.40
32
299
(3011288) Drugs identified in Urine by Screen method
18
187
0.96
0.01
1.3
2.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
14
133
1.06
0.01
1.6
1.9
u/ml
239.1
175.0
—
8
59
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
134
1.05
0.00
1.6
1.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
24
234
1.03
0.00
2.9
5.4
mg/l
0.5
1.4
1.33
14
161
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
124
0.96
0.00
1.3
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
51
515
0.99
0.00
2.7
2.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
22
215
1.02
0.00
10.4
14.3
mmol/l
6.1
5.1
0.56
22
210
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
159
1.01
0.00
1.3
1.3
u/ml
3.9
3.1
0.08
11
99
(3032080) INR in Blood by Coagulation assay
30
300
1.00
0.00
2.5
4.1
inr
1.1
1.1
1.24
18
97
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
17
168
1.01
0.00
2.8
3.2
ng/l
2143.7
1350.3
—
7
85
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
119
1.01
0.00
1.0
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
21
213
0.98
0.00
2.3
2.3
ng/l
13.6
15.8
—
7
69
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
110
1.00
0.00
1.1
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
12
123
0.97
0.00
1.4
2.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
20.6
—
0
5
(3004616) Nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4024509)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
2000.0
—
0
5
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
1.8
—
0
5
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
25.4
—
0
5
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4146454)
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
67
0.89
0.00
1.3
2.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
8
0.00
0.00
0.0
6.9
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
59
0.84
0.00
6.2
11.8
—
96.7
—
0
7
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
107.6
—
0
5
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
0
5
0.00
0.00
0.0
1.2
—
1.4
—
0
5
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
7.4
—
3.7
—
0
5
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3032641) Amino acids panel - Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
7
69
1.01
0.00
2.0
4.2
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
4.4
—
4.3
—
0
7
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
64
0.93
0.00
1.7
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
61
0.98
0.00
5.2
12.7
—
425.5
—
0
13
(3041354) Potassium [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
2.5
—
3.5
—
0
6
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
49
1.02
0.00
11.4
13.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
803.7
—
0
7
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
6
60
1.00
0.00
11.7
14.1
%
0.9
1.2
—
6
60
(1175426) CD3 cells/100 lymphocytes in Blood
5
49
1.02
0.00
1.4
4.4
%
67.4
68.8
—
5
49
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
57
0.87
0.00
1.2
1.4
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
6
60
1.00
0.00
11.7
14.1
%
0.6
0.7
—
6
60
(3013727) Leukocytes other/100 leukocytes in Blood
0
7
0.00
0.00
0.0
12.4
—
46.4
—
0
7
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
8.1
—
647.4
—
0
7
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
68
0.88
0.00
2.2
1.5
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
7
0.00
0.00
0.0
13.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
79
1.01
0.00
1.6
1.9
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
5
56
0.89
0.00
1.4
4.9
%
22.6
16.5
—
5
56
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
49
1.02
0.00
1.4
4.4
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
5
58
0.86
0.00
13.6
14.5
mmol/l
24.0
24.1
—
5
58
(3032773) Endomysium IgG Ab [Titer] in Serum
5
57
0.87
0.00
1.0
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
2.5
—
107.3
—
0
6
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD – Other infections specific to the perinatal period
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data